Two Sigma Investments, LP Atreca, Inc. Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.59 - $2.74 $45,787 - $78,903	-28,797 Reduced 64.1%	16,128 $25,000
Q2 2022 Aug 15, 2022	BUY	$1.56 - $3.25 $70,083 - $146,006	44,925 New	44,925 $80,000
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $480,428 - $1.55 Million	-298,403 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.87 - $6.29 $746,366 - $1.64 Million	260,058 Added 678.21%	298,403 $904,000
Q3 2021 Nov 15, 2021	BUY	$4.91 - $9.07 $122,175 - $225,688	24,883 Added 184.84%	38,345 $239,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $13.8 $375,594 - $662,814	-48,030 Reduced 78.11%	13,462 $115,000
Q1 2021 May 17, 2021	BUY	$13.0 - $19.34 $155,324 - $231,074	11,948 Added 24.12%	61,492 $943,000
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $645,558 - $846,706	49,544 New	49,544 $800,000
Q3 2020 Nov 16, 2020	SELL	$12.67 - $23.19 $268,413 - $491,280	-21,185 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.52 - $23.45 $265,236 - $496,788	21,185 New	21,185 $451,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.